Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Seqirus
Administration route
Intramuscular injection
Vaccine group
Japanese encephalitis vaccines
Description:
Registered for use in people aged ≥18 years.
Inactivated Japanese encephalitis vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 6 antigen units of purified inactivated Japanese encephalitis virus
- 0.25 mg aluminium as aluminium hydroxide
- 0.1% aluminium hydroxide hydrate
- Phosphate Buffered Saline
Also contains traces of:
- protamine sulphate
- formaldehyde
- bovine
- serum albumin
- host cell DNA
- sodium metabisulphite or host cell protein
No preservatives or antibiotics are added.
For Product Information and Consumer Medicine Information about JEspect visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases